Pharmacoeconomic analyses in healthcare are paramount, because of the high costs of innovative technologies and limited possibilities of their funding. Budget Impact Analysis (BIA) is one such analysis that provides vital information for healthcare decision makers .
Unlike economic evaluations, such as cost-effectiveness analysis (CEA), cost-utility analysis (CUA) and cost-benefit analysis (CBA) that evaluate the costs and consequences of healthcare; budget impact analysis (BIA) predicts the financial impact of the adoption and diffusion of innovation. Budget impact analysis (with budget impact models) also addresses the expected changes in expenditure of a healthcare system after adopting a new intervention. Decision-makers also use budget impact analysis for resource planning  .
Organisations who manage and plan healthcare budgets also use budget impact models to align pricing with resources, that is finding an optimal price for each intervention. This includes administrators of regional or national budgets, private health insurance plans, healthcare delivery organisations and employers who pay for healthcare. Each user’s requirement may differ, but each requires information on the financial impact of the adoption and diffusion of the new intervention .
Though based on the principles of accounting, budget impact analysis is not an economic evaluation (includes cost-effectiveness analysis (CEA), cost-utility analysis (CUA) and cost-benefit analysis (CBA)). There are key distinct differences [Table 1] between the two  :
The proper design of an analytical framework [Figure 1] is a crucial step in budget impact analysis. It enables a practical comparison between the current treatment and condition, with the new scenario that would result from adopting a new intervention. The framework allows examination of the impact of the intervention on the healthcare system, by assessing disease, incidence, diagnosis and treatment, and resource and costs. The next step is to compare the total costs of each scenario to estimate the budget impact of the innovation. Researchers require certain inputs to construct the BIA modelling framework    and enable data drive   :
Budget impact analysis is an essential part of a Health Technology Assessment  . A budget impact analysis serves several important functions:
In a cost-conscious market, providers are under extreme pressure to show the real value of their products. Budget impact analysis is as important as a cost-effective analysis to build a firm position for adopting a new intervention. It is flexible enough to allow efficient estimates of the cost of treatment for a certain condition, and display how each new intervention impacts on total treatment  .
Budget impact analysis complements the information for a comprehensive Health Technology Assessment. It is complementary to more established types of economic evaluations, namely cost-effectiveness analysis, by providing additional information on the financial consequences of reimbursement of new technologies . However, as a comprehensive HTA takes time and is labour intensive, decision-makers may use a budget impact analysis in isolation to determine the financial impact of an innovation .
Budget impact analysis also assesses affordability by estimating an intervention’s short-term net costs from the payer’s perspective  . The outcomes of a budget impact analysis reflects scenarios with a specific set of assumptions and data inputs of interest to the decision makers  . It provides a structured framework that allows users to see how different assumptions results in changes in the treatment mix and cost of treating that condition .
Although a new intervention is generally expensive, it may reduce overall costs because of reduced hospital days and out-patient visits. A budget impact analysis that shows a reduction in overall disease cost, is an added motivation for reimbursement .
Researchers apply six steps to conduct a budget impact analysis. These are preceded by developing an analytic framework to guide data collection and populate a budget impact model with data relevant to the budget holder   :
A budget impact analysis is used to assess whether adopting a new health innovation is affordable, given resource and budget constraints . Budget impact analysis is important as part of a Health Technology Assessment when combined with a cost-effectiveness analysis for reimbursement. It is also important for budget and forecast planning, estimating the impact of health technology changes on health insurance premiums and estimating potential fiscal impact on pursuing an intervention at national level  .
Budget impact analysis may be conducted in isolation or part of a comprehensive analysis with complementary economic evaluations for HTA  . In addition, managers can make strategic decisions, as BIA estimates the financial feasibility of a new intervention in a healthcare . The budget impact analysis services at Syenza determine the optimal price of innovations by identifying opportunities for dynamic pricing and outcomes based pricing. Our budget impact models also align pricing with value, and articulate key success factors in value-based pricing frameworks. Learn more here and contact us for further details.
 R. I. Yagudina, A. U. Kulikov, V. G. Serpik and et.al, “Concept of Combining Cost-Effectiveness Analysis and Budget,” Value in Health Regional Issues, vol. 13C, pp. 61-66, 2017.
 S. D. Sullivan, J. A. Mauskopf, F. Augustovski and et.al, “Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR Task Group,” Value in Health, vol. 17, pp. 5-14, 2014.
 P. Leelahavarong, “Budget Impact Analysis,” J Med Assoc Thai, vol. 97, no. Suppl 5, pp. S65-S71, 2014.
 Health Information and Quality Authority, “Guidelines for the Budget Impact Analysis of Health Technologies in Ireland,” Health Information and Quality Authority (HIQA), Dublin, 2018.
 L. Garattini and K. van de Vooren, “Budget impact analysis in economic evaluation: a proposal for a clearer definition,” The European Journal of Health Economics, pp. 449-502, 2011.
 M. T. Silva, E. N. da Silva and M. G. Pereira, “Budget impact analysis,” Epidemiol. Serv. Saude, vol. 26, no. 2, pp. 1-4, 2017.
 J. B. Babigumira, “Budget Impact Analysis,” School of Public Health University of Washington, Seattle, 2017.
 A. Bilinski, P. Neumann, J. Cogen and et.al, “When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs,” Plos Medicine, vol. 14, no. 10, pp. 1-10, 2017.
 L. Steuten, “Budget Impact Analysis,” University of Washington, Seattle, 2017.
What is value-based pricing? Value-based pricing aims to reward pharmaceutical companies and medical device companies for investments in new healthcare technologies that result in sustained improvements in patient quality of life. We also expect such technologies to deliver measurable net economic benefits for society. In economic theory, value-based pricing is when a buyer’s willingness to […]Read all
Introduction The market access landscape in the Middle East and North Africa is changing rapidly. The region is diverse, comprises many dissimilar countries, and different cultures including languages used in commerce. There are also different approaches to regulating healthcare markets, and concerns about the long-term sustainability of oil revenues shape healthcare markets. There are other […]Read all
Introduction Private healthcare markets comprise individuals and entities that are not owned or operated by the government. Individuals finance private healthcare services from disposal income, or pooled premium contributions through private health insurance providers. The provision and financing of private healthcare services does not include funding by the government. There are several advantages for patients […]Read all